Skip to main content
Premium Trial:

Request an Annual Quote

NCBI Now Accepts 454 Sequencer 20 Data

NEW YORK, Jan. 27 (GenomeWeb News) - Researchers generating sequence data with 454 Life Sciences' technology can now submit their data to the National Center for Biotechnology Information, 454 said today.


454's new standard flowgram format is the first new sequence trace format adopted by the NCBI since the Sanger method, said the company.


Penn State's Stephan Schuster, who recently sequenced the wooly mammoth DNA, was the first to submit his data in the SFF format, according to a 454 statement. "The submission of our sequencing data allowed for the results to be publicly available prior to the publication of our article," said Schuster.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.